Cantourage Group SE

HIGH

DE000A3DSV01

Drug Retailers

Real-time Estimate Tradegate Other stock markets 04:09:29 2024-05-21 EDT			5-day change	1st Jan Change
7.1 ^EUR	+1.43%		-2.10%	-2.51%

05-14	WDH/Survey: Seven percent of adults have bought cannabis seeds	DP
03-27	Cannabis law signed - release on April 1	DP

Cantourage Group SE Provides Earnings Guidance for the Fiscal Year 2023

July 20, 2023 at 02:30 am

Cantourage Group SE provided earnings guidance for the fiscal year 2023. For the year, the company expects sales growth to be in the higher double-digit percentage range compared to the previous year.

Latest news about Cantourage Group SE

WDH/Survey: Seven percent of adults have bought cannabis seeds	05-14	DP
Cannabis law signed - release on April 1	03-27	DP
Controversial cannabis law has been signed	03-27	DP
TOTAL Federal Council paves the way for growth package and cannabis	03-22	DP
Federal Council clears the way for cannabis legalization	03-22	DP
Synbiotic continues to rise after cannabis legalization	03-22	DP
Circles/Cannabis dispute: Hesse wants to abstain in the Bundesrat	03-22	DP
Cannabis dispute: Baden-Württemberg in favor of mediation committee	03-22	DP
Synbiotic corrects after cannabis rally - legalization open	03-22	DP
Daniel Günther: Cannabis law to be postponed until October	03-22	DP
Cannabis dispute: Baden-Württemberg calls for mediation committee	03-22	DP
Cannabis law and clinic atlas in the Bundesrat	03-22	DP
Dreyer does not expect cannabis law to fail	03-19	DP
Drugs commissioner lobbies states for cannabis law	03-15	DP
Union interior ministers want to consider legal action against cannabis legalization	03-12	DP
Bundestag approves controlled cannabis release	02-23	DP
Synbiotic share price fireworks continue - cannabis approval imminent	02-23	DP
Bundestag decides on cannabis and naval deployment	02-22	DP
Greens: Cannabis legalization overdue - CDU/CSU: Historic mistake	02-21	DP
Legislative plans for cannabis legalization in committee	02-20	DP
Lauterbach defends cannabis approval - further criticism	02-20	DP
Juvenile court judge Müller warns against scaremongering on cannabis	02-13	DP
SHARES IN FOCUS 2: Synbiotic and Cantourage rally - risk of correction feared	02-05	DP
SHARES FOCUS: Cannabis legalization drives Synbiotic and Cantourage upwards	02-05	DP
Cantourage Group SE Provides Earnings Guidance for the Fiscal Year 2023	23-07-20	CI

Chart Cantourage Group SE

Duration

Period

More charts

Company Profile

Cantourage Group SE is a Germany-based holding company. The Company offers products in market segments such as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. The object of Cantourage GmbH is the production of and wholesale trade in cannabis-based medicinal preparations and trade in other cannabis products.

Sector

Drug Retailers

Calendar

2024-06-25 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7 EUR

Average target price

10 EUR

Spread / Average Target

+42.86%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Cannabis Product Retailers

	1st Jan change	Capi.
CANTOURAGE GROUP SE	-2.51%	94.81M
GREEN THUMB INDUSTRIES INC.	+18.70%	3.07B
VERANO HOLDINGS CORP.	+18.71%	1.77B
GLASS HOUSE BRANDS INC.	+97.67%	671M
TERRASCEND CORP.	+11.82%	527M
HIGH TIDE INC.	+40.38%	174M
MARIMED INC.	-9.02%	94.91M
GOLD FLORA CORPORATION	+37.50%	63.28M
NOVA CANNABIS INC.	+40.45%	57.02M

Cannabis Product Retailers